Select Bibliography

Filter by any of these (after searching):

There are 555 items

Platelet count at baseline (Plt) and outcomes in patients (pts) with advanced hepatocellular carcinoma (HCC) treated with sorafenib (S) in CALGB 80802 (Alliance) (C8)

Abou-Alfa, Ghassan K. , Shi, Qian , Knox, Jennifer J. ... - ASCO - J Clin Oncol - 2018

Abstract - Secondary-not-in-original - Primary - GI - CALGB-80802

Correlation between polymorphisms in the reduced folate carrier gene (SLC19A1) and survival after pemetrexed-based therapy in non-small cell lung cancer (NSCLC): An NCCTG N0026 based study. Abstract 198.

Adjei, A. , Salavaggione, O. , Mandrekar, S. , Dy, G. ... - NCI TSM - - 2009

Abstract - Secondary-not-in-original - Primary - Respiratory - NCCTG-N0026

Correlation between polymorphisms of the reduced folate carrier gene (SLC19A1) and survival after pemetrexed-based therapy in non-small cell lung cancer: a North Central Cancer Treatment Group-based exploratory study.

Adjei, Araba A , Salavaggione, Oreste E , Mandrekar, Sumithra J ... - - J Thorac Oncol - 2010

Manuscript - Secondary-not-in-original - Primary - Respiratory - N0026

Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E-IPI).

Advani, Ranjana H , Chen, Haiyan , Habermann, Thomas M ... - - Br. J. Haematol. - 2010

Manuscript - Secondary-not-in-original - Primary - Older Adult - C9793

The Effect of Prior Androgen Synthesis Inhibition on Outcomes of Subsequent Therapy with Docetaxel in Patients with Metastatic Castrate Resistant Prostate Cancer: Results from a Retrospective Analysis of a Randomized Phase 3 Clinical Trial (CALGB 90401) (Alliance)

Aggarwal, Rahul , Halabi, Susan , Kelly, William Kevin ... - - Cancer - 2013

Manuscript - Secondary-not-in-original - Primary - GU - CALGB-90401

Comparative analysis of outcomes in African American (AA) and white (W) patients (pts) with multiple myeloma (MM) treated with lenalidomide (LEN) or pomalidomide (POM) CALGB 100104 (Alliance)

Ailawadhi, Sikander , McCarthy, Philip L. , Holstein, Sarah A. ... - ASCO - J Clin Oncol - 2018

Abstract - Secondary-not-in-original - Meta-Analysis - Transplant - CALGB-100104 , E4A03 , MM-002 , MM-009

Comparative Age-Based Prospective Multi-Institutional Observations from 12,367 Patients Enrolled to American College of Surgeons Oncology Group (ACOSOG Z901101) Trials (Alliance)

Al-Refaie, Waddah B. , Decker, Paul A. , Ballman, Karla V. ... - - Ann. Surg. Oncol. - 2019

Manuscript - Secondary-not-in-original - Meta-Analysis - Older Adult - Z901101

Attributes and Outcomes of Older Adults in Surgical Oncology Trials: Results from ACOSOG Z901101 (Alliance)

Al-Refaie, Waddah B. , Decker, Paul A. , Pisters, Peter W.T. ... - SSO - Ann. Surg. Oncol. - 2015

Abstract - Secondary-not-in-original - Comprehensive - Older Adult - Z901101

Computed tomography densitometry and morphology of radiofrequency ablated Stage IA non-small cell lung cancer: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial

Alexander, Erica S. , Xiong, Lillian , Baird, Grayson L. ... - - J Vasc Interv Radiol - 2020

Manuscript - Secondary-not-in-original - Primary - Respiratory - ACOSOG-Z4033

ACOSOG Z0030 Study Group: Number of lymph nodes harvested from a mediastinal lymphadenectomy: results of the randomized, prospective ACOSOG Z0030 trial

Allen, M. S. , Darling, G. E. , Decker, P. A. , Putnam, J. B. Jr ... - - J. Clin. Oncol. - 2007

Abstract - Secondary-not-in-original - Primary - Respiratory - ACOSOG-Z0030

Perioperative mortality and Morbidity after Lobar versus Sublobar Resection for early stage lung cancer: A post-hoc analysis of an international randomized phase III trial (CALGB/Alliance 140503)

Altorki, Nasser K. , Wang, Xiaofei , Wigle, Dennis , Gu, Lin ... - - Lancet Respir Med - 2018

Manuscript - Secondary-not-in-original - Primary - Respiratory - ACOSOG-Z0010

Perioperative mortality and Morbidity after Lobar versus Sublobar Resection for early stage lung cancer: A post-hoc analysis of an international randomized phase III trial (CALGB/Alliance 140503)

Altorki, Nasser K. , Wang, Xiaofei , Wigle, Dennis , Gu, Lin ... - AATS - - 2018

Abstract - Secondary-not-in-original - Primary - Respiratory - CALGB-140503

Par-4 Down-regulation Promotes Breast Cancer Recurrence by Preventing Multinucleation following Targeted Therapy

Alvarez, James V. , Pan, Tien-chi , Ruth, Jason , Feng, Yi ... - - Cancer Cell - 2013

Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - CALGB-150007

Clinical Utility of Metrics Based on Tumor Measurements in Phase II Trials to Predict Overall Survival Outcomes in Phase III Trials by Using Resampling Methods

An, Ming-Wen , Han, Yu , Meyers, Jeffrey P. , Bogaerts, Jan ... - - J. Clin. Oncol - 2015

Manuscript - Secondary-not-in-original - Primary - GI - NCCTG-N9741

Exploring the statistical and clinical impact of two interim analyses on the phase II design with option for direct assignment

An, Ming-Wen , Mandrekar, Sumithra J. , Edelman, Martin J. ... - - Contemp Clin Trials - 2014

Manuscript - Secondary-not-in-original - Primary - Respiratory - CALGB-30203

Missing tumor measurement (TM) data in the search for alternative TM-based endpoints in cancer clinical trials

An, Ming-Wen , Tang, Jun , Grothey, Axel , Sargent, Daniel J. ... - - Contemp Clin Trials Commun - 2019

Manuscript - Secondary-not-in-original - Primary - GI - A151817 , N0026 , N9741 , NCCTG-N9741

Single nucleotide polymorphisms (SNPs) and circulating endothelial cells (CECs) as outcome predictors in recurrent glioblastoma (rGBM) patients (pts) treated with bevacizumab (BEV) and sorafenib (SOR).

Anderson, S. K. , Lafky, J. M. , Carrero, X. W. , Kimlinger, T. K. ... - - J. Clin. Oncol. - 2011

Abstract - Secondary-not-in-original - Primary - Neuro-Onc - NCCTG-N0776

Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials

André, Thierry , Meyerhardt, Jeffrey , Iveson, Timothy ... - - Lancet Oncol - 2020

Manuscript - Secondary-not-in-original - Primary - GI - CALGB-80702

Immune Checkpoint Profiles in Luminal B Breast Cancer (Alliance).

Anurag, Meenakshi , Zhu, Mayanne , Huang, Chen , Vasaikar, Suhas ... - - J. Natl. Cancer Inst. - 2020

Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - ACOSOG-Z1031

Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy

Apolo, Andrea B. , Ostrovnaya, Irina , Halabi, Susan ... - - J. Natl. Cancer Inst - 2013

Manuscript - Secondary-not-in-original - Primary - GU - CALGB-90102

External validation of prognostic models for overall survival (OS) in patients (pts) with advanced cancer (UC) treated with cisplatin-based chemotherapy.

Apolo, Andrea Borghese , Philips, George , Ostrovnaya, Irina ... - - J. Clin. Oncol. - 2012

Abstract - Secondary-not-in-original - Primary - GU - CALGB-90102

Lenalidomide (LEN) maintenance (MNTC) after high-dose melphalan and autologous stem cell transplant (ASCT) in multiple myeloma (MM): A meta-analysis (MA) of overall survival (OS) CALGB 100104 (Alliance)

Attal, Michel , Palumbo, Antonio , Holstein, Sarah ... - ASCO - J. Clin. Oncol. - 2016

Abstract - Secondary-not-in-original - Primary - Myeloma - CALGB-100104

Treatment of older patients with de novo acute myeloid leukemia (AML) with one or more postremission chemotherapy courses: Analysis of four CALGB studies

Baer, M. R. , George, S. L. , Sanford, B. L. , Stone, R. M. ... - ASCO - J. Clin. Oncol. - 2010

Abstract - Secondary-not-in-original - Comprehensive - Leukemia - C8525 , CALGB-10201 , CALGB-8923 , CALGB-9720

A Genome-Wide Association Study Identifies Novel Loci for Paclitaxel-Induced Sensory Peripheral Neuropathy in CALGB 40101

Baldwin, R. Michael , Owzar, Kouros , Zembutsu, Hitoshi ... - - Clin. Cancer Res. - 2012

Manuscript - Secondary-not-in-original - Primary - PPP - CALGB-40101

Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target

Bao, Riyue , Surriga, Oliver , Olson, Daniel J. , Allred, Jacob B. ... - - Melanoma Res - 2021

Manuscript - Secondary-not-in-original - Primary - Experimental - A091201

Adjuvant chemotherapy for resected stage II and III colon cancer: Comparison of widely used two prognostic calculators

Bardia, A. , Loprinzi, C. , Grothey, A. , Nelson, G. , Alberts, S. ... - - J. Clin. Oncol. - 2009

Abstract - Secondary-not-in-original - Primary - GI - NCCTG-N0148

Adjuvant Chemotherapy for Resected Stage II and III Colon Cancer: Comparison of Two Widely Used Prognostic Calculators

Bardia, Aditya , Loprinzi, Charles , Grothey, Axel , Nelson, Garth ... - - Semin Oncol - 2010

Manuscript - Secondary-not-in-original - Primary - GI - N0148

Composite Grading Algorithm for the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Basch, Ethan , Becker, Claus , Rogak, Lauren J. , Schrag, Deborah ... - - Clin Trials - 2021

Manuscript - Secondary-not-in-original - Primary - Health Outcome - A091105

Development of a Composite Scoring Algorithm for the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) (Alliance)

Basch, Ethan , Becker, Claus , Rogak, Lauren , Spears, Patricia ... - ISOQOL - - 2019

Abstract - Secondary-not-in-original - Primary - Health Outcome - A091105

Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials

Basch, Ethan , Dueck, Amylou C. , Rogak, Lauren J. ... - - JAMA Oncol - 2017

Manuscript - Secondary-not-in-original - Meta-Analysis - Health Outcome - CALGB-30607 , CALGB-30610 , CALGB-40502 , CALGB-40503 , CALGB-40601 , CALGB-70604 , CALGB-70501 , CALGB-80405 , CALGB-90401

Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048

Basch, Ethan , Dueck, Amylou C. , Rogak, Lauren J. ... - - J. Clin. Oncol - 2018

Manuscript - Secondary-not-in-original - Primary - Health Outcome - N1048

Her2 gene expression and not Her2 amplification is predictive and prognostic in patients (pts) with metastatic colorectal cancer (mCRC) enrolled in CALGB/SWOG 80405 (Alliance)

Battaglin, Francesca , Ou, Fang-Shu , Qu, Xueping ... - ASCO - J. Clin. Oncol - 2020

Abstract - Secondary-not-in-original - Primary - Correl Sci NOS - CALGB-80405

Comparison of Clinical and Biologic Significance of WT1 Mutations in Populations of Older (>= 60 years y ) and Younger (< 60 y) Adult Patients (Pts) with Cytogenetically Normal (CN) De Novo Acute Myeloid Leukemia (AML): a Cancer and Leukemia Group B (CALGB) Study

Becker, H. , Marcucci, G. , Maharry, K. , Radmacher, M. D. ... - - Blood - 2009

Abstract - Secondary-not-in-original - Primary - Correl Sci NOS - C8525 , CALGB-10201 , CALGB-19808 , CALGB-20202 , CALGB-20502 , CALGB-8461 , CALGB-8923 , CALGB-9420 , CALGB-9621 , CALGB-9665 , CALGB-9720

Impact of therapy on genomics and transcriptomics in high-risk prostate cancer treated with neoadjuvant docetaxel and androgen deprivation therapy

Beltran, Himisha , Wyatt, Alexander W , Chedgy, Edmund C ... - - Clin. Cancer Res. - 2017

Manuscript - Secondary-not-in-original - Primary - GU - CALGB-90203

High-Dose Chemotherapy With Autologous Stem-Cell Support As Adjuvant Therapy in Breast Cancer: Overview of 15 Randomized Trials

Berry, Donald A. , Ueno, Naoto T. , Johnson, Marcella M. ... - - J. Clin. Oncol - 2011

Manuscript - Secondary-not-in-original - Comprehensive - Breast - INT-0163

Sequencing symptom control: Results from the Alliance N08C1 and N08CA genetics of chemotherapy neuropathy trials

Beutler, A. S. , Kulkarni, A. , Kanwar, R. , Qin, R. ... - AACR - AACR 2013 Annual Meeting - 2013

Abstract - Secondary-not-in-original - Primary - Symptom Inter - N08C1 , N08CA

Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy

Beutler, Andreas S. , Kulkarni, Amit A. , Kanwar, Rahul ... - - Ann. Neurol. - 2014

Manuscript - Secondary-not-in-original - Meta-Analysis - Symptom Inter - N08C1 , N08CA

Clinical and molecular characterization of patients with acute myeloid leukemia and sole trisomies of chromosomes 4, 8, 11, 13 or 21

Bhatnagar, Bhavana , Eisfeld, Ann-Kathrin , Kohlschmidt, Jessica ... - - Leukemia - 2020

Manuscript - Secondary-not-in-original - Primary - Leuk Corr Sci - C8461 , C9665 , CALGB-20202

Acute myeloid leukemia (AML) patients with an isolated trisomy display increased frequency of spliceosome mutations CALGB 8461 and 20202 (Alliance)

Bhatnagar, Bhavana , Eisfeld, Ann-Kathrin , Mrózek, Krzysztof ... - ASH - Blood - 2017

Abstract - Secondary-not-in-original - Primary - Leuk Corr Sci - CALGB-20202 , CALGB-8461

Poor Survival and Differential Impact of Genetic Features of Black Patients with Acute Myeloid Leukemia.

Bhatnagar, Bhavana , Kohlschmidt, Jessica , Mrózek, Krzysztof ... - - Cancer Discov - 2020

Manuscript - Secondary-not-in-original - Primary - Leuk Corr Sci - CALGB-20202 , CALGB-8461 , CALGB-9665

Discovery of SNPs associated with chemotherapy-induced peripheral neuropathy (CIPN) using model estimated parameters as phenotypes CALGB 40502 (Alliance)

Bhongsatiern, Jiraganya , Carbonetto, P. , Chua, Katherina C. ... - ASCPT - CLINICAL PHARMACOLOGY & THERAPEUTICS - 2018

Abstract - Secondary-not-in-original - Primary - PPP - CALGB-40502

Mutational Landscape and Clinical Outcome Associated with Different Rearrangements Involving 11q23/MLL in De Novo Acute Myeloid Leukemia (AML) CALB 8461 and 20202 (Alliance)

Bill, Marius , Eisfeld, Ann-Kathrin , Mrózek, Krzysztof ... - ASH - Blood - 2017

Abstract - Secondary-not-in-original - Primary - Leuk Corr Sci - CALGB-20202 , CALGB-8461

Differential Impact of Prognostically Significant Gene Mutations in Acute Myeloid Leukemia (AML) Patients (Pts) Older Than 70 Years (y) Treated With a Cytarabine-Based Induction Therapy (Alliance)

Bill, Marius , Kohlschmidt, Jessica , Mrózek, Krzysztof ... - ASH - Blood - 2020

Abstract - Secondary-not-in-original - Primary - Leuk Corr Sci - CALGB-20202 , CALGB-8461 , CALGB-9665

Prognostic impact of the 2017 European Leukemianet (ELN) classification of adult patients (pts) with acute myeloid leukemia (AML) treated on Cancer and Leukemia Group B (CALGB)/Alliance protocols

Bill, Marius , Mrózek, K , Kohlschmidt, J. , Nicolet, D. ... - EHA - HemaSphere - 2019

Abstract - Secondary-not-in-original - Meta-Analysis - Leuk Corr Sci - C8461 , CALGB-20202 , CALGB-9665

Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/KMT2A

Bill, Marius , Mrózek, Krzysztof , Kohlschmidt, Jessica ... - - Proc Natl Acad Sci U S A - 2020

Manuscript - Secondary-not-in-original - Primary - Leuk Corr Sci - CALGB-20202 , CALGB-8461 , CALGB-9665

Validation of the prognostic significance of the knowledge bank (KB) algorithm in adult acute myeloid leukemia (AML) patients (pts) treated on Cancer and Leukemia Group B (CALGB)/Alliance protocols and suggestions for improvements

Bill, Marius , Mrózek, Krzysztof , Kohlschmidt, Jessica ... - EHA - - 2020

Abstract - Secondary-not-in-original - Primary - Leuk Corr Sci - CALGB-20202 , CALGB-8461 , CALGB-9665

Personalized Oncology in Acute Myeloid Leukemia (AML): Validation of the Prognostic Value of the Knowledge Bank Approach in Patients (Pts) Treated on Cancer and Leukemia Group B/Alliance Protocols

Bill, Marius , Mrózek, Krzysztof , Kohlschmidt, Jessica ... - ASH - Blood - 2019

Abstract - Secondary-not-in-original - Primary - Leukemia - CALGB-20202 , CALGB-8461 , CALGB-9665

A 17-gene leukemia stem cell (LSC) score in adult patients (pts) with acute myeloid leukemia (AML) reveals a distinct mutational landscape and refines current European Leukemianet (ELN) genetic risk stratification (Alliance)

Bill, Marius , Nicolet, Deedra , Eisfeld, Ann-Kathrin ... - ASH - Blood - 2018

Abstract - Secondary-not-in-original - Primary - Leuk Corr Sci - CALGB-20202 , CALGB-8461

Mutations associated with a 17-gene leukemia stem cell score and the score’s prognostic relevance in the context of the European LeukemiaNet classification of acute myeloid leukemia

Bill, Marius , Nicolet, Deedra , Kohlschmidt, Jessica ... - - Haematologica - 2020

Manuscript - Secondary-not-in-original - Primary - Leuk Corr Sci - C8621 , CALGB-8461 , C8721 , CALGB-10201 , CALGB-10502 , CALGB-10503 , CALGB-10603 , CALGB-11001 , CALGB-11002 , CALGB-19808 , CALGB-20202 , CALGB-8525 , CALGB-8821 , CALGB-8923 , CALGB-9022 , CALGB-9120 , CALGB-9222 , CALGB-9420 , CALGB-9621 , CALGB-9665 , CALGB-9720

Prognostic and biologic significance of transfer RNA-derived small RNAs(tsRNAs) expression in younger adult patients (pts) with cytogenetically normal acute myeloid leukemia (CN-AML)

Bill, Marius , Veneziano, Dario , Kohlschmidt, Jessica ... - ASH - Blood - 2018

Abstract - Secondary-not-in-original - Primary - Leuk Corr Sci - C8461 , C9665 , CALGB-20202

Impact of young (Y) age on efficacy and safety in advanced colorectal cancer (aCRC): A pooled analysis examining 6,286 patients (pts) from nine first-line phase III chemotherapy (CT) trials

Blanke, C. D. , Bot, B. M. , Thomas, D. M. , Bleyer, A. , Kohne, C. ... - - J. Clin. Oncol. - 2010

Abstract - Secondary-not-in-original - Comprehensive - GI - NCCTG-N9741

Impact of Young Age on Treatment Efficacy and Safety in Advanced Colorectal Cancer: A Pooled Analysis of Patients From Nine First-Line Phase III Chemotherapy Trials

Blanke, Charles D. , Bot, Brian M. , Thomas, David M. ... - - J. Clin. Oncol - 2011

Manuscript - Secondary-not-in-original - Comprehensive - GI - N9741

Meta-analyses of 22 randomized trials assessing the influence of chemotherapy in advanced/recurrent gastric cancer.

Bleiberg, H. ... - ASCO - J. Clin. Oncol. - 2011

Abstract - Secondary-not-in-original - Comprehensive - GI - NCCTG-79-41-51 , NCCTG-83-41-51

Laparoscopically assisted vs open colectomy for colon cancer: a meta-analysis.

Bonjer, H Jacob , Hop, Wim C J , Nelson, Heidi , Sargent, Daniel J ... - - Arch Surg - 2007

Manuscript - Secondary-not-in-original - Comprehensive - GI - NCCTG-1515

Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance)

Boora, Ganesh K. , Kanwar, Rahul , Kulkarni, Amit A. , Abyzov, Alexej ... - - Cancer Med - 2016

Manuscript - Secondary-not-in-original - Primary - Symptom Inter - N08C1

Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance)

Boora, Ganesh K. , Kulkarni, Amit A. , Kanwar, Rahul ... - - J. Neurol. Sci. - 2015

Manuscript - Secondary-not-in-original - Primary - Symptom Inter - N08CA

Identification and resection of the clipped node decreases the false negative rate of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0-T4, N1-2) who receive neoadjuvant chemotherapy – results from ACOSOG Z1071 (Alliance)

Boughey, Judy C. , Ballman, Karla V. , Le-Petross, Huong T. ... - - Ann. Surg. - 2016

Manuscript - Secondary-not-in-original - Primary - Breast - ACOSOG-Z1071

Predictors of locoregional recurrence after neoadjuvant chemotherapy and surgery for node positive breast cancer: Results from ACOSOG Z1071 (Alliance)

Boughey, Judy C. , Ballman, Karla , McCall, Linda ... - SABCS - Cancer Res. - 2017

Abstract - Secondary-not-in-original - Primary - Breast - ACOSOG-Z1071

Effect of the use of immediate reconstruction on the rates of bilateral mastectomy and adjuvant radiation therapy use in women with node-positive breast cancer treated with neoadjuvant chemotherapy on ACOSOG Z1071 (Alliance).

Boughey, Judy C. , McCall, Linda , Haffty, Bruce , Buchholz, Tom ... - ASCO - J. Clin. Oncol. - 2015

Abstract - Secondary-not-in-original - Primary - Breast - ACOSOG-Z1071

LACE-Bio: validation of prognostic role of tumour lymphocytic infiltration in resectable non small cell lung cancer

Brambilla, E. , Domerg, C. , Lantuejoul, S. , Kratzke, R. ... - - J Thorac Oncol - 2012

Abstract - Secondary-not-in-original - Comprehensive - Respiratory - CALGB-9633

LACE-Bio: results of pooled analysis of prognostic and predictive values of histology and lymphocytic infiltration

Brambilla, E. , Tsao, M. , Paris, E. , Lantuejoul, S. ... - - Ann. Oncol. - 2010

Abstract - Secondary-not-in-original - Comprehensive - Respiratory - CALGB-9633

Grain Intake and Clinical Outcome in Stage III Colon Cancer: Results From CALGB 89803 (Alliance)

Brown, Justin C , Zhang, Sui , Niedzwiecki, Donna , Saltz, Leonard B ... - - JNCI Cancer Spectr - 2018

Manuscript - Secondary-not-in-original - Primary - GI - CALGB-89803

Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance)

Brown, Justin C , Zhang, Sui , Ou, Fang-Shu , Venook, Alan P ... - - JNCI Cancer Spectr - 2019

Manuscript - Secondary-not-in-original - Primary - GI - CALGB-80405

What is the added value of actual tumor measurements (TM) in predicting overall survival (OS)? The North Central Cancer Treatment Group (NCCTG) findings

Campbell, M. E. , Mandrekar, S. J. , Hillman, S. L. , Goldberg, R. M. ... - ASCO - J. Clin. Oncol. - 2008

Abstract - Secondary-not-in-original - Comprehensive - GI - NCCTG-N0026 , NCCTG-N9741

Waterfall plots provide detailed information on magnitude of response to conventional chemotherapy in advanced colorectal cancer (ACRC) - lessons learned from N9741.

Campbell, M. , Grothey, A. , Sargent, D. ... - - J. Clin. Oncol. - 2007

Abstract - Secondary-not-in-original - Primary - GI - N9741

Impact of KRAS mutations on adjuvant carboplatin/paclitaxel in surgically resected stage IB NSCLC: CALGB 9633

Capelletti, M. , Wang, X. F. , Gu, L. , Graziano, S. L. ... - - J. Clin. Oncol. - 2010

Abstract - Secondary-not-in-original - Primary - Correl Sci NOS - CALGB-9633

Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (Alliance) clinical trials

Castillo, Jorge J. , Mulkey, Flora , Geyer, Susan ... - - Am. J. Hematol. - 2016

Manuscript - Secondary-not-in-original - Meta-Analysis - Leukemia - C9621 , C9710 , CALGB-10503 , CALGB-19808

Obesity Is An Adverse Prognostic Factor For Overall and Disease-Free Survival In Adult Acute Promyelocytic Leukemia But Not In Acute Myeloid Leukemia: A Pooled Analysis From Four Alliance Prospective Studies

Castillo, Jorge J. , Mulkey, Flora , Geyer, Susan ... - - Blood - 2013

Abstract - Secondary-not-in-original - Comprehensive - Leukemia - CALGB-9621 , CALGB-9710 , CALGB-10503 , CALGB-19808

Examiner accuracy in cognitive testing in multisite brain-tumor clinical trials: an analysis from the Alliance for Clinical Trials in Oncology

Cerhan, Jane H , Anderson, S Keith , Butts, Alissa M , Porter, Alyx B ... - - Neurooncol Pract - 2019

Manuscript - Secondary-not-in-original - Primary - Health Outcome - N0577 , A221101 , N0874 , N107C

Association of Family History with Cancer Recurrence and Survival Among Patients with Stage III Colon Cancer

Chan, Jennifer A. , Meyerhardt, Jeffrey A. , Niedzwiecki, Donna ... - - JAMA - 2008

Manuscript - Secondary-not-in-original - Primary - GI - C89803

Quality-adjusted time without symptoms or toxicity (Q-TWiST): analysis of cabozantinib versus sunitinib in patients with advanced renal cell carcinoma of intermediate or poor risk (Alliance A031203)

Chen, RC , Feuilly, M , Meng, J , Lister, J , Marteau, F , Morris, M ... - ASCO - J Clin Oncol - 2018

Abstract - Secondary-not-in-original - Primary - GU - A031203

Quality-adjusted survival with first-line cabozantinib or sunitinib for advanced renal cell carcinoma in the CABOSUN randomized clinical trial (Alliance).

Chen, Ronald C , Choueiri, Toni K , Feuilly, Marion , Meng, Jie ... - - Cancer - 2020

Manuscript - Secondary-not-in-original - Primary - GU - A031203

Bayesian Variable Selection with Joint Modeling of Categorical and Survival Outcomes: An Application to Individualizing Chemotherapy Treatment in Advanced Colorectal Cancer

Chen, Wei , Ghosh, Debashis , Raghunathan, Trivellore E. ... - - Biometrics - 2009

Manuscript - Secondary-not-in-original - Primary - GI - NCCTG-9741

Polygenic Inheritance of Paclitaxel-Induced Sensory Peripheral Neuropathy Driven by Axon Outgrowth Gene Sets in CALGB 40101 (Alliance)

Chhibber, Aparna , Mefford, Joel , Stahl, Eli A. ... - - Pharmacogenomics J. - 2014

Manuscript - Secondary-not-in-original - Primary - PPP - CALGB-40101

PD-L1 status and clinical outcomes to cabozantinib, sunitinib and everolimus in patients with metastatic clear-cell RCC treated on CABOSUN and METEOR clinical trials

Choueiri, T.K. , Flaifel, A. , Xie, W. , Braun, D. , Ficial, M. ... - ESMO - Annal Oncol - 2018

Abstract - Secondary-not-in-original - Primary - GU - A031203

Meta-analysis identifies variants in S1PR1 associated with microtubule targeting agent-induced sensory peripheral neuropathy CALGB 40101 and 40502 (Alliance)

Chua, Katherina C. , Ho, Carol , Mushiroda, Tasei , Jiang, Chen ... - ASCPT - Clinical Pharmacology & Therapeutics - 2018

Abstract - Secondary-not-in-original - Meta-Analysis - Breast - CALGB-40101 , CALGB-40502

Genome-Wide Meta-Analysis Validates a Role for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy

Chua, Katherina C. , Xiong, Chenling , Ho, Carol , Mushiroda, Taisei ... - - Clin Pharmacol Ther - 2020

Manuscript - Secondary-not-in-original - Meta-Analysis - PPP - CALGB-40101 , CALGB-40502

Incidence of late recurrence in hormone receptor-positive or negative HER2-positive breast cancer receiving adjuvant trastuzumab: The combined analysis of the NCCTG (Alliance) N9831 and NSABP (NRG) B31 Trials

Chumsri, Saranya , Li, Zhou , Serie, Daniel J. ... - SABCS - Cancer Res - 2018

Abstract - Secondary-not-in-original - Primary - GI - NCCTG-N9831 , NSABP B-31

Incidence of Late Relapses in Patients With HER2-Positive Breast Cancer Receiving Adjuvant Trastuzumab: Combined Analysis of NCCTG N9831 (Alliance) and NRG Oncology/NSABP B-31

Chumsri, Saranya , Li, Zhuo , Serie, Daniel J. ... - - J. Clin. Oncol - 2019

Manuscript - Secondary-not-in-original - Primary - Breast - N9831 , NSABP B-31

Effects of Age and Immune Landscape on Outcome in HER2-positive Breast Cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) Trials

Chumsri, Saranya , Serie, Daniel J. , Li, Zhuo ... - - Clin. Cancer Res. - 2019

Manuscript - Secondary-not-in-original - Primary - Breast - N9831 , NSABP B-31

Association between adaptive immune signature and outcome in HER2-positive breast cancer treated with trastuzumab and lapatinib in the NCCTG-N9831 (Alliance) and NeoALTTO trials

Chumsri, Saranya , Serie, Daniel , Mashadi-Hossein, Afshin ... - ASCO - J Clin Oncol - 2018

Abstract - Secondary-not-in-original - Primary - GI - N9831

High p95HER2/HER2 Ratio Associated With Poor Outcome in Trastuzumab-Treated HER2-Positive Metastatic Breast Cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance)

Chumsri, Saranya , Sperinde, Jeff , Liu, Heshan , Gligorov, Joseph ... - - Clin. Cancer Res. - 2018

Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - N0337 , N98-32-52

Correlation of high p95HER2:HER2 ratio with poor outcome in two phase II clinical trials of trastuzumab-treated HER2-positive metastatic breast cancer.

Chumsri, Saranya , Sperinde, Jeff , Liu, Heshan , Gligorov, Joseph ... - ASCO - J Clin Oncol - 2016

Abstract - Secondary-not-in-original - Primary - Breast - N0337 , N98-32-52

Combination trastuzumab and chemotherapy to induce immunity to multiple tumor antigens in patients with HER2-positive metastatic breast cancer: NCCTG (Alliance) studies N0337 and N98-32-52

Clynes, R. , Knutson, K. L. , Ballman, K. , Erskine, C. L. ... - ASCO - J. Clin. Oncol. - 2013

Abstract - Secondary-not-in-original - Primary - Breast - N0337 , N98-32-52

Acute Myeloid Leukemia (AML) with 9q aberrations occuring within a non-complex karyotype is highly associated with CEBPA and NPM1 mutations - A joint analysis of the German-Austrian AML Study Group (AMLSG) and Cancer and Leukemia Group B (CALGB)

Corbacioglu, A. , Frohling, S. , Paschka, P. , Marcucci, G. ... - ASH - Blood - 2007

Abstract - Secondary-not-in-original - Primary - Leuk Corr Sci - CALGB-19808 , CALGB-8461 , CALGB-9621 , CALGB-9665

A pooled exploratory analysis of the effect of tumor size on survival benefit from adjuvant platinum-based chemotherapy (ACT) in node negative (N0) non-small cell lung cancer (NSCLC)

Cuffe, S. , Ezzalfani, M. , Bourredjem, A. , Graziano, S. L. ... - Chicago MSTO - - 2010

Abstract - Secondary-not-in-original - Primary - Respiratory - CALGB-9633

A Pooled Exploratory Analysis of the Impact of Tumor Size and KRAS Mutations on Survival Benefit from Adjuvant Platinum-Based Chemotherapy (ACT) in Node Negative (N0) Non-Small Cell Lung Cancer (NSCLC).

Cuffe, S. , Graziano, S. , Bourredjem, A. , Pignon, J. P. ... - - J Thorac Oncol - 2011

Abstract - Secondary-not-in-original - Primary - Respiratory - CALGB-9633

A Pooled Exploratory Analysis of the Effect of Tumor Size and KRAS Mutations on Survival Benefit from Adjuvant Platinum-Based Chemotherapy in Node Negative Non-Small Cell Lung Cancer

Cuffe, Sinead , Bourredjem, Abderrahmane , Graziano, Stephen ... - - J Thorac Oncol - 2012

Manuscript - Secondary-not-in-original - Comprehensive - Respiratory - CALGB-9633

Validation of EORTC Prognostic Factors for Adults with Low-Grade Glioma: a Report Utilizing Intergroup 86-72-511

Daniels, Thomas B. , Brown, Paul D. , Felten, Sara J. , Wu, Wenting ... - - Int J Radiat Oncol Biol Phys - 2011

Manuscript - Secondary-not-in-original - Primary - Neuro-Onc - NCCTG-86-72-51

Number of Lymph Nodes Harvested From a Mediastinal Lymphadenectomy

Darling, Gail E. , Allen, Mark S. , Decker, Paul A. , Ballman, Karla ... - - Chest - 2011

Manuscript - Secondary-not-in-original - Primary - Respiratory - ACOSOG-Z0030

Causal modeling of CALGB/SWOG 80405 (Alliance) identifies primary (1°) side-related angiogenic drivers of metastatic colorectal cancer (mCRC)

Das, R K , Furchtgott, L , Ou, F-S , Swanson, D , Hayete, B , Harms, B ... - ESMO - Ann Oncol - 2018

Abstract - Secondary-not-in-original - Primary - GI - CALGB-80405

Bayesian machine learning on CALGB/SWOG 80405 (Alliance) and PEAK data identifies heterogeneous landscape of clinical predictors of overall survival (OS) in different populations of metastatic colorectal cancer (mCRC)

Das, Rahul K , Ou, Fang-Shu , Washburn, Cecilia , Nixon, Andrew B. ... - ESMO GI - Annals of Oncology - 2019

Abstract - Secondary-not-in-original - Primary - GI - CALGB-80405

Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665

DeBoer, Rebecca , Koval, Gregory , Mulkey, Flora , Wetzler, Meir ... - - Leuk. Lymphoma - 2016

Manuscript - Secondary-not-in-original - Primary - Leuk Corr Sci - CALGB-10001 , C9665

Impact of trial development time on accruals at CCOPs: The case of the MARVEL trial.

Dilts, D. M. , Adjei, A. A. , Mandrekar, S. J. , Buckner, J. C. ... - - J. Clin. Oncol. - 2010

Abstract - Secondary-not-in-original - Comprehensive - Respiratory - NCCTG-N0723

Sublobar Resection and Iodine-125 Brachytherapy for Stage 1 NSCLC, Initial Quality Assurance Review of ACOSOG Z-4032

Dipetrillo, T. A. , Heron, D. E. , Landreneau, R. J. , Logan, D. ... - ASTRO - Int. J. Radiat. Oncol. Biol. Phys. - 2009

Abstract - Secondary-not-in-original - Primary - Respiratory - ACOSOG-Z4032

Clinical and Genome Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer

Dolan, M. Eileen , El Charif, Omar , Wheeler, Heather E. ... - - Clin. Cancer Res. - 2017

Manuscript - Secondary-not-in-original - Primary - PPP - CALGB-90401

Participation in cancer pharmacogenomic studies in 8,456 patients registered to Cancer and Leukemia Group B (Alliance) clinical trials

Dressler, L. G. , Deal, A. M. , Watson, D. , Hollis, D. , Owzar, K. ... - - J. Clin. Oncol. - 2013

Abstract - Secondary-not-in-original - Meta-Analysis - Health Outcome - CALGB-40101 , CALGB-50303 , CALGB-80203 , CALGB-80303 , CALGB-80405 , CALGB-90401

Participation in Cancer Pharmacogenomic Studies: A Study of 8456 Patients Registered to Clinical Trials in the Cancer and Leukemia Group B (Alliance)

Dressler, Lynn G. , Deal, Allison M. , Owzar, Kouros ... - - J. Natl. Cancer Inst - 2015

Manuscript - Secondary-not-in-original - Meta-Analysis - Health Outcome - CALGB-40101 , CALGB-50303 , CALGB-80101 , CALGB-80203 , CALGB-80303 , CALGB-80405 , CALGB-90401

Endpoint comparison for bone mineral density measurements in North Central Cancer Treatment Group cancer clinical trials N02C1 and N03CC (Alliance)

Dueck, A. C. , Singh, J. , Atherton, P. , Liu, H. , Novotny, P. ... - - Osteoporos Int - 2015

Manuscript - Secondary-not-in-original - Primary - Health Outcome - N02C1 , N03CC

Calibrating clinically significant effects in survival and response endpoints in cancer clinical trials.

Dueck, A. , Sargent, D. , Novotny, P. , Decker, P. , Nelson, H. ... - ASCO - J. Clin. Oncol. - 2011

Abstract - Secondary-not-in-original - Primary - Health Outcome - N0591

Quality of life (QOL) among patients (pts) with HER2+ breast cancer (bc) treated with adjuvant lapatinib and/or trastuzumab in the ALTTO study (BIG 2-06, Alliance N063D).

Dueck, Amylou C. , Hillman, David W. , Kottschade, Lisa A. ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Secondary-not-in-original - Primary - Breast - N063D

Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia

Döhner, Konstanze , Thiede, Christian , Jahn, Nikolaus ... - - Blood - 2020

Manuscript - Secondary-not-in-original - Primary - Leuk Corr Sci - CALGB-10603

Prognostic and predictive impact of NPM1/FLT3-ITD genotypes as defined by 2017 European LeukemiaNet (ELN) risk categorization from randomized patients with acute myeloid leukemia (AML) treated within the International RATIFY Study (ALLIANCE 10603)

Döhner, Konstanze , Thiede, Christian , Jahn, Nikolaus ... - EHA - HemaSphere - 2019

Abstract - Secondary-not-in-original - Primary - Leukemia - CALGB-10603

Prognostic impact of NPM1/FLT3-ITD genotypes from randomized patients treated within the RATIFY/CALGB 10603 (Alliance) Study

Döhner, Konstanze , Thiede, Christian , Larson, Richard A. ... - ASH - Blood - 2017

Abstract - Secondary-not-in-original - Primary - Leukemia - CALGB-10603

The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia

Eisfeld, A-K , Mrózek, K , Kohlschmidt, J , Nicolet, D , Orwick, S ... - - Leukemia - 2017

Manuscript - Secondary-not-in-original - Meta-Analysis - Leuk Corr Sci - CALGB-20202 , CALGB-8461 , CALGB-9665

Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 years

Eisfeld, Ann-Kathrin , Kohlschmidt, Jessica , Mims, Alice ... - - Leukemia - 2020

Manuscript - Secondary-not-in-original - Meta-Analysis - Leuk Corr Sci - CALGB-10503 , CALGB-10603 , CALGB-19808 , CALGB-8525 , CALGB-8821 , CALGB-9022 , CALGB-9222 , CALGB-9621

Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studies

Eisfeld, Ann-Kathrin , Kohlschmidt, Jessica , Mrózek, Krzysztof ... - - Leukemia - 2018

Manuscript - Secondary-not-in-original - Meta-Analysis - Leuk Corr Sci - C8461 , C8525 , C8821 , C9665 , CALGB-10201 , CALGB-10502 , CALGB-11001 , CALGB-11002 , CALGB-20202 , CALGB-8461 , CALGB-8923 , CALGB-9420 , CALGB-9720

NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome

Eisfeld, Ann-Kathrin , Kohlschmidt, Jessica , Mrózek, Krzysztof ... - - Leukemia - 2018

Manuscript - Secondary-not-in-original - Primary - Leuk Corr Sci - C8525 , C8821 , C9022 , C9621 , C9720 , CALGB-10201 , CALGB-10502 , CALGB-10503 , CALGB-10603 , CALGB-19808 , CALGB-8923

Additional gene mutations refine the 2017 European Leukemianet (ELN) classification of adult patients (pts) with de novo acute myeloid leukemia (AML) aged <60 years: An analysis of Alliance studies

Eisfeld, Ann-Kathrin , Kohlschmidt, Jessica , Mrózek, Krzysztof ... - ASH - Blood - 2018

Abstract - Secondary-not-in-original - Primary - Leuk Corr Sci - C8461 , CALGB-20202

Mutations in genes associated with familial predisposition to myeloid neoplasms:their frequency and associations with pretreatment characteristics in adult patients (pts) with presumably sporadic de novo acute myeloid leukemia (AML) (Alliance)

Eisfeld, Ann-Kathrin , Kohlschmidt, Jessica , Mrózek, Krzysztof ... - ASH - Blood - 2018

Abstract - Secondary-not-in-original - Primary - Leuk Corr Sci - C8461 , CALGB-20202

The 2017 European LeukemiaNet Genetic Risk Classification performs poorly in elderly Acute Myeloid Leukemia (AML) patients and should be refined to enable identification of patients requiring additional or alternative treatment (Alliance)

Eisfeld, Ann-Kathrin , Kohlschmidt, Jessica , Mrózek, Krzysztof ... - ASH - Blood - 2019

Abstract - Secondary-not-in-original - Primary - Leukemia - CALGB-20202 , CALGB-8461 , CALGB-9665

Mutational landscape and gene-expression patterns in adult acute myeloid leukemias with monosomy 7 as a sole abnormality

Eisfeld, Ann-Kathrin , Kohlschmidt, Jessica , Mrózek, Krzysztof ... - - Cancer Res. - 2017

Manuscript - Secondary-not-in-original - Meta-Analysis - Leuk Corr Sci - CALGB-10201 , CALGB-10503 , CALGB-10603 , CALGB-11002 , CALGB-19808 , CALGB-20202 , CALGB-8461 , CALGB-8525 , CALGB-9222 , CALGB-9420 , CALGB-9621

Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma

Ellingson, Benjamin M , Abrey, Lauren E , Nelson, Sarah J ... - - Neuro-oncology - 2018

Manuscript - Secondary-not-in-original - Primary - Neuro-Onc - N0874

Whole-genome analysis informs breast cancer response to aromatase inhibition

Ellis, M. J. , Ding, L. , Shen, D. , Luo, J. Q. , Suman, V. J. ... - - Nature - 2012

Manuscript - Secondary-not-in-original - Comprehensive - PPP - ACOSOG-Z1031

Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer

Ellis, Matthew J , Lin, Li , Crowder, Robert , Tao, Yu , Hoog, Jeremy ... - - Breast Cancer Res Treat - 2010

Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - ACOSOG-Z1031

Nut Consumption and Survival in Stage III Colon Cancer Patients: Results from CALGB 89803 (Alliance)

Fadelu, Temidayo , Zhang, Sui , Niedzwiecki, Donna , Ye, Xing ... - ASCO - J. Clin. Oncol. - 2017

Abstract - Secondary-not-in-original - Primary - GI - CALGB-89803

Comparison of Reduced-Intensity Hematopoietic Cell Transplantation with Chemotherapy in Patients Aged 60–70 Years with Acute Myeloid Leukemia in First Remission

Farag, Sherif S. , Maharry, Kati , Zhang, Mei-Jie , Pérez, Waleska S. ... - - Biol. Blood Marrow Transplant. - 2011

Manuscript - Secondary-not-in-original - Comprehensive - Leukemia - CALGB-9720 , CALGB-10201

ECOG score analysis as a proxy for health-related quality of life assessment in patients with poor or intermediate risk metastatic renal cell carcinoma from the CABOSUN trial (Alliance A031203)

Feldman, D , Feuilly, M , Meng, J , Lister, J , Marteau, F , Morris, MJ ... - ASCO - J Clin Oncol - 2018

Abstract - Secondary-not-in-original - Primary - GU - A031203

Genomic predictive biomarkers to anti-HER2 targeted therapies: a combined analysis of CALGB 40601 (Alliance) and PAMELA clinical trials

Fernandez-Martinez, Aranzazu , Tanioka, Maki , Fan, Cheng ... - ASCO - J. Clin. Oncol. - 2019

Abstract - Secondary-not-in-original - Primary - Breast - CALGB-40601

The Impact of Adjuvant Brachytherapy with Sublobar Resection on Pulmonary Function and Dyspnea in High-risk Operable Patients; Preliminary results from the ACOSOG Z4032 Trial

Fernando, Hiran C , Landreneau, Rodney J , Mandrekar, Sumithra J ... - - J Thorac Cardiovasc Surg - 2011

Manuscript - Secondary-not-in-original - Primary - Respiratory - ACOSOG-Z4032

Validation of the lung cancer staging system revisions using a large prospective clinical trial database (ACOSOG Z0030)

Fibla, J. J. , Cassivi, S. D. , Decker, P. A. , Allen, M. S. ... - - J. Clin. Oncol. - 2010

Abstract - Secondary-not-in-original - Primary - Respiratory - ACOSOG-Z0030

Validation of the lung cancer staging system revisions using a large prospective clinical trial database (ACOSOG Z0030)

Fibla, Juan J. , Cassivi, Stephen D. , Decker, Paul A. ... - - Eur J Cardiothorac Surg - 2013

Manuscript - Secondary-not-in-original - Primary - Respiratory - ACOSOG-Z0030

Association of Immunophenotype With Pathologic Complete Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Secondary Analysis of the BrighTNess Phase 3 Randomized Clinical Trial.

Filho, Otto Metzger , Stover, Daniel G , Asad, Sarah ... - - JAMA Oncol - 2021

Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - AFT-04

Molecular Subtypes and Response to Neoadjuvant Chemotherapy in TNBC: Results from Brightness Phase III Study AFT-04 (Alliance)

Filho, Otto Metzger , Stover, Daniel , Asad, Sarah , Ansell, Peter ... - ASCO - J Clin Oncol - 2019

Abstract - Secondary-not-in-original - Primary - Breast - AFT-04

Comparison of progression-free survival (PFS) and tumor response as endpoints for predicting overall survival (OS) in untreated extensive-stage small cell lung cancer (ED-SCLC): Findings based on North Central Cancer Treatment Group (NCCTG) trials.

Foster, N. R. , Qi, Y. , Krook, J. E. , Kugler, J. W. , Kuross, S. A. ... - - J. Clin. Oncol. - 2009

Abstract - Secondary-not-in-original - Comprehensive - Respiratory - N0424

Multitrial evaluation of progression-free survival (PFS) as a surrogate endpoint for overall survival (OS) in previously untreated extensive-stage small cell lung cancer (ES-SCLC): An Alliance-led analysis

Foster, N. R. , Renfro, L. A. , Schild, S. E. , Redman, M. W. ... - - J. Clin. Oncol. - 2013

Abstract - Secondary-not-in-original - Meta-Analysis - Respiratory - Comprehensive , CALGB-9033 , CALGB-9732 , CALGB-30103 , NCCTG-862051 , NCCTG-892051 , NCCTG-932053 , ECOG-1500 , ECOG-7593 , JCOG-9511 , NCIC-BR4 , NCIC-BR8 , SWOG-S0124

Multi-Trial Evaluation of Progression-Free Survival (PFS) as a Surrogate Endpoint for Overall Survival (OS) in First-Line Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Foster, Nathan R. , Renfro, Lindsay A. , Schild, Steven E. ... - - J Thorac Oncol - 2015

Manuscript - Secondary-not-in-original - Meta-Analysis - Respiratory - CALGB-30103 , N0424 , NCCTG-932053

Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of NCCTGs phase III trials N9741 and N9841.

Franko, J. , Shi, Q. , Goldman, C. D. , Pockaj, B. A. , Nelson, G. D. ... - - J. Clin. Oncol. - 2011

Abstract - Secondary-not-in-original - Comprehensive - GI - N9841 , N9741

Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841

Franko, Jan , Shi, Qian , Goldman, Charles D. , Pockaj, Barbara A. ... - - J Clin Oncol - 2012

Manuscript - Secondary-not-in-original - Comprehensive - GI - N9841 , N9741

Model-based prediction of defective DNA mismatch repair using clinicopathological variables in stage II and III colon cancers.

French, A. , Sinicrope, F. , Foster, N. , Thibodeau, S. , Sargent, D. ... - - J. Clin. Oncol. - 2009

Abstract - Secondary-not-in-original - Comprehensive - GI - N994C

Statistical modeling of CALGB 80405 (Alliance) to identify influential factors in metastatic colorectal cancer (CRC) dependent on primary tumor side.

Furchtgott, Leon , Swanson, David , Hayete, Boris , Khalil, Iya ... - ASCO - J. Clin. Oncol. - 2017

Abstract - Secondary-not-in-original - Primary - GI - CALGB-80405

The Preference to Receive Chemotherapy and Cancer-related Outcomes in Older Adults with Breast Cancer CALGB 49907 (Alliance)

Gajra, Ajeet , McCall, Linda , Muss, Hyman B. , Cohen, Harvey J ... - - J Geriatr Oncol - 2018

Manuscript - Secondary-not-in-original - Primary - Older Adult - CALGB-49907

Treatment-influenced associations of PML-RARalpha mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia

Gallagher, R. E. , Moser, B. K. , Racevskis, J. , Poire, X. ... - - Blood - 2012

Manuscript - Secondary-not-in-original - Primary - Leuk Corr Sci - C9710

Clonal Markers In Relapsed Acute Promyelocytic Leukemia (APL): Clinicopathological Associations and Relation to All-Trans Retinoic Acid (ATRA) Treatment on Intergroup Phase III Trial C9710

Gallagher, R. E. , Moser, B. K. , Racevskis, J. , Poire, X. ... - - Blood - 2010

Abstract - Secondary-not-in-original - Primary - Leuk Corr Sci - C9710

RasGRP1 is a potential biomarker for stratifying anti-EGFR therapy response in colorectal cancer

Gbenedio, Oghenekevwe M. , Bonnans, Caroline , Grun, Delphine ... - - JCI Insight - 2019

Manuscript - Secondary-not-in-original - Primary - GI - CALGB-80203

Cabozantinib versus sunitinib for previously untreated patients with advanced renal cell carcinoma (RCC) of intermediate or poor risk: subgroup analysis of progression-free survival (PFS) and objective response rate (ORR) in the Alliance A031203 CABOSUN trial

George, Daniel , Hessel, Colin , Halabi, Susan , Sanford, Ben ... - ASCO GU - J Clin Oncol - 2018

Abstract - Secondary-not-in-original - Primary - GU - A031203

Central Pathology Review by Whole Slide Imaging in Glioblastoma Clinical Trials

Giannini, Caterina , Miller, Ryan , Ligon, Keith , Tollefson, Helen ... - AANP - J Neuropathol Expl Neurol - 2015

Abstract - Secondary-not-in-original - Meta-Analysis - Neuro-Onc - N0872 , N0877

Analysis of prognostic (prog) Web-based models for stage II and III colon cancer (CC): A population-based validation of Numeracy (NUM) and ADJUVANT! Online (ADJ!).

Gill, S. , Loprinzi, C. , Kennecke, H. , Grothey, A. , Nelson, G. ... - - J. Clin. Oncol. - 2009

Abstract - Secondary-not-in-original - Comprehensive - GI - N0148

Prognostic Web-based Models for Stage II and III Colon Cancer: a Population and Clinical Trials-based Validation of Numeracy and Adjuvant! Online

Gill, Sharlene , Loprinzi, Charles , Kennecke, Hagen , Grothey, Axel ... - - Cancer - 2011

Manuscript - Secondary-not-in-original - Meta-Analysis - GI - NCCTG-89-46-51 , NCCTG-914653

Loss of Heterozygosity at the CYP2D6 Locus in Breast Cancer: Implications for Germline Pharmacogenetic Studies

Goetz, Matthew P. , Sun, James X. , Suman, Vera J. , Silva, Grace O. ... - - J. Natl. Cancer Inst - 2014

Manuscript - Secondary-not-in-original - Primary - PPP - NCCTG-89-30-52

A pooled safety and efficacy analysis examining the effect of performance status (PS) on outcomes in 9 first line treatment (rx) trials (cts) of 6,286 patients (pts) with metastatic colorectal cancer (MCRC).

Goldberg, R. M. , Kohne, C. H. , Seymour, M. T. , De Gramont, A. ... - - J. Clin. Oncol. - 2007

Abstract - Secondary-not-in-original - Comprehensive - GI - N0545 , N9741

Variability of Pelvic MRI Performance in a Prospective Multicenter Rectal Cancer Trial NCCTG N1048 (Alliance)

Gollub, Marc J. , Shi, Qian , Nougaret, Stephanie ... - ASCO - J Clin Oncol - 2018

Abstract - Secondary-not-in-original - Primary - GI - N1048

Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II–III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance)

Golshan, Mehra , Cirrincione, Constance T. , Sikov, William M. ... - - Breast Cancer Res. Treat. - 2016

Manuscript - Secondary-not-in-original - Primary - Breast - CALGB-40601

Predictors of accrual success for cooperative group trials: The Cancer and Leukemia Group B (Alliance) experience

Gordon, David , Liu, Qianying , Kleinman, Benjamin ... - ASCO - J. Clin. Oncol. - 2013

Abstract - Secondary-not-in-original - Meta-Analysis - Health Outcome - Comprehensive

Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer (NSCLC) treated with adjuvant chemotherapy: Results from IALT, JBR.10 and ANITA

Graziano, S. L. , Pignon, J. P. , Vollmer, R. T. , Kratzke, R. A. ... - IASLC (WCLC) - J Thorac Oncol - 2009

Abstract - Secondary-not-in-original - Comprehensive - Respiratory - CALGB-9633

LACE-Bio pooled analysis of the prognostic and predictive value of p53 mutations and expression by Immunohistochemistry (IHC) in patients with resected Non-Small Cell Lung Cancer (NSCLC).

Graziano, S. , Paris, E. , Ma, X. , Pignon, J. , Hainaut, P. ... - - Ann. Oncol. - 2010

Abstract - Secondary-not-in-original - Primary - Respiratory - CALGB-9633

Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: results from IALT, JBR.10 and ANITA

Graziano, Stephen L. , Lacas, Benjamin , Vollmer, Robin ... - - Lung Cancer - 2013

Manuscript - Secondary-not-in-original - Primary - Respiratory - CALGB-9633

Evaluating Treatment Tolerability in Cancer Clinical Trials Using the Toxicity Index

Gresham, Gillian , Diniz, Márcio A , Razaee, Zahra S , Luu, Michael ... - - J Natl Cancer Inst - 2020

Manuscript - Secondary-not-in-original - Primary - - NSABP R-04

Accuracy of FDG-PET to diagnose lung cancer in the ACOSOG Z4031 trial

Grogan, E. , Deppen, S. , Ballman, K. , Andrade, G. , Verdail, F. ... - - J. Clin. Oncol. - 2012

Abstract - Secondary-not-in-original - Primary - Respiratory - ACOSOG-Z4031

Accuracy of FDG-PET within the clinical practice of the ACOSOG Z4031 trial to diagnose clinical stage I NSCLC

Grogan, Eric L. , Deppen, Stephen A. , Ballman, Karla V. ... - - Ann. Thorac. Surg. - 2014

Manuscript - Secondary-not-in-original - Primary - Respiratory - ACOSOG-Z4031

New lesions vs. growth of existing disease: does it impact prognosis?

Grothey, A. , Heun, J. M. , Branda, M. , Goldberg, R. M. ... - ASCO -